This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
HealthdirectFree Australian health advice you can count on. — Description, Dosage, Side Effects | PillsCard
OTC
HealthdirectFree Australian health advice you can count on.
1100 mg/11mL, Solution, concentrate
INN: RAVULIZUMAB
Available in:
🇬🇧🇵🇹
Form
SOLUTION, CONCENTRATE
Dosage
1100 mg/11mL
Route
INTRAVENOUS
Storage
—
About This Product
Manufacturer
Alexion Pharmaceuticals Inc.
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
ATC Code
L04AJ02
Source
OPENFDA_NDC
(
ARTG
)
Ultomiris is indicated:, for the treatment of patients with Paroxysmal Nocturnal Haemoglobinuria (PNH), for the treatment of patients with Atypical Haemolytic Uraemic Syndrome (aHUS), as an add-on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive., for the treatment of adult patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) who are anti-aquaporin 4 (AQP4) antibody-positive.,Ultomiris is not intended for the acute treatment of a NMOSD relapse.
⚠️ Warnings
•Life-threatening meningococcal infections could occur in patients treated with Ravulizumab. They should be addressed immediately.
• Follow the recommendations of the current Advisory Committee on Immunization Practices (ACIP) for meningococcal vaccination among patients with complement deficiencies two weeks before usage of ravulizumab.
• Ravulizumab is available under Risk Evaluation and Mitigation Strategy (REMS). Healthcare professionals who prescribe ravulizumab must enroll in the ravulizumab REMS.
• Caution is needed while prescribing ravulizumab to patients with systemic infections.
• After stopping the treatment, monitor for signs and symptoms of hemolysis for 16 weeks.
• These Signs include decrease in haemoglobin, or re-appearance of fatigue, hemoglobinuria, abdominal pain, breathing difficulties, thrombosis (blood clotting), dysphagia (painful swallowing), or erectile dysfunction.
PillsCard reference image